ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH LOPEZ MD

Cardiovascular Disease

6,643

$252K

434
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$38
Average prescription price

Avg: $67

RAIF TAWAKOL MD

Cardiovascular Disease

6,643

$761K

113
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

52%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$115
Average prescription price

Avg: $67

ROBERT STEIN M.D.

Cardiovascular Disease

6,600

$260K

423
395 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$39
Average prescription price

Avg: $67

WILLIAM MADRID M.D.

Cardiovascular Disease

6,596

$247K

434
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$38
Average prescription price

Avg: $67

KAMRAN MATIN M.D.

Cardiovascular Disease

6,591

$490K

323
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $67

RUPINDER BRAR MD

Cardiovascular Disease

6,556

$361K

709
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $67

FAYE MONTEGRANDE MD

Cardiovascular Disease

6,534

$316K

285
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $67

RICHARD SEIDMAN M.D.

Cardiovascular Disease

6,510

$231K

403
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

MARTIN CHARLAT M.D.

Cardiovascular Disease

6,507

$535K

634
585 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$82
Average prescription price

Avg: $67

KENNETH TWAY

Cardiovascular Disease

6,497

$324K

408
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

MICHAEL KRUEGER DO

Cardiovascular Disease

6,487

$443K

848
708 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

DAVID GILLON M.D.

Cardiovascular Disease

6,485

$406K

476
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $67

MICHAEL DAM MD

Cardiovascular Disease

6,479

$150K

1051
978 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$23
Average prescription price

Avg: $67

RAMACHANDRA SETTY M.D.

Cardiovascular Disease

6,451

$298K

434
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $67

JOSEPH LEE MD

Cardiovascular Disease

6,425

$390K

544
500 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $67

CHARLES OKONKWO M.D.

Cardiovascular Disease

6,422

$566K

142
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

54%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $67

GEORGE WESLEY M.D.

Cardiovascular Disease

6,418

$311K

444
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $67

ZAHIDA BHUTTO MD

Cardiovascular Disease

6,372

$308K

351
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $67

HONG-LING LEE M.D.

Cardiovascular Disease

6,365

$397K

268
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

22%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $67

PRAKASH PATEL MD

Cardiovascular Disease

6,361

$284K

367
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$45
Average prescription price

Avg: $67

MADHUSUDHAN GUPTA M.D.

Cardiovascular Disease

6,319

$321K

455
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $67

KIRK CHANG M.D

Cardiovascular Disease

6,303

$531K

358
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 28%

$84
Average prescription price

Avg: $67

BRIAN STRUNK M.D.

Cardiovascular Disease

6,303

$584K

495
468 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 28%

$93
Average prescription price

Avg: $67

MASSOUD ALIPOUR MD

Cardiovascular Disease

6,300

$324K

240
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $67

JORGE PENA M.D.

Cardiovascular Disease

6,298

$285K

294
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 28%

$45
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank